From ECHO NEWSNG
Scientific findings have shown that the two important components for the formulation of a drug for treatment of HID/AIDS are abundant in commercial quantities in Nigeria.
Both can become a source massive foreign exchange for the country to replace earnings from crude oil.
Prof. Maduike C. O. Ezeibe, a Nigerian professor of Veterinary Medicine, Department of Veterinary Medicine, Michael Okpara University of Agriculture, Umudike, Umuahia told a news conference Feb. 1 at Umuahia.
“ Nigeria does not have AMS, as a natural resource, but there is abundance of Aluminum silicate and Magnesium silicate in the country, indeed in commercial quantity, enough to make a difference in the country’s foreign exchange earnings.
“These two minerals, which are also safe medicines were reacted to get a purer form of AMS.’’
He said that these minerals had been in use to potentiate Ampicilin, Chloroquine, Piperazine and Sulphadimidin, among others, and could be a major foreign exchange earner for Nigeria, if approved by relevant authorities.
According to him, local and international pharmaceutical companies will find the product as veritable raw materials.
Ezeibe said that he presented the research findings to the World Virology Conference in Atlanta in 2015, and Antonio (Texas) in 2016.
Besides, he said that the results of the laboratory tests had been published in many international scientific journals, including the British Journal of Medicine and Medical Research, among several others.
He said that he was also about to sign a memorandum of understanding with a U.S.-based Scientific Research Publishing, publishers of World Journal of AIDS, for the publication of his book “How I came about the cure for HIV/AIDS’’.
Ezeibe, who said the medicine was patented in August 2014 in Nigeria, called on the Federal Government to help him to secure international patency for the drug.
According to him, if commercialised, the Medicinal Synthetic Aluminum-Magnesium Silicate will become an alternative for petroleum to the Nigerian economy.
It was at the news conference in Umuahia that Prof. Francis Otunta, the Vice-Chancellor, Michael Okpara University of Agriculture, Umudike, Umuahia, Abia State that confirmed the discovery of a new drug for the treatment and cure of HIV/AIDS by the institution.
Otunta said that the finding followed years of scientific research by the institution and that the breakthrough was made by Prof. Ezeibe, a researcher in the institution.
According to him, Ezeibe had presented the drug to the University management, Senate and Council, where he explained the processes he went through to arrive at his finding.
The VC also said that Ezeibe had presented the drug to his colleagues in the medical field and nobody had contradicted his finding.
“Prof. Ezeibe as a researcher in Veterinary Medicine, one may wonder how he discovered a drug to cure a human ailment,” he said.
He commended Ezeibe for the breakthrough, saying: “he has brought honour to the University and we are proud of him.’’
Otunta said the university was in the process of mass producing the drug for further clinical trials on persons living with HIV/AIDS in the country.
Prof. Ezeibe was a graduate of University of Nigeria, Nsukka from where he obtained Doctor of Veterinary Medicine Degree (DVM), M.Sc and Ph.D.
He is also a fellow of College of Veterinary Surgeons, Nigeria (FCVSN).
Prof Ezeibe has won many academic prizes, including: best student in Veterinary microbiology, pathology, public health and jurisprudence and in Veterinary clinics.
In 2011 he won Federal Government’s Presidential Standing Committee Award, for invention of Medicinal synthetic Aluminum – magnesium silicate (Nanoparticles)- a broad-spectrum antiviral medicine.
These have proved effective against Avian influenza virus, Measles virus, Newcastle disease virus, Peste des petits ruminants virus, Infectious bursal disease virus, Egg drop syndrome 76 virus, Avian pox virus and Canine parvovirus.
Scientific findings have shown that the two important components for the formulation of a drug for treatment of HID/AIDS are abundant in commercial quantities in Nigeria.
Both can become a source massive foreign exchange for the country to replace earnings from crude oil.
Prof. Maduike C. O. Ezeibe, a Nigerian professor of Veterinary Medicine, Department of Veterinary Medicine, Michael Okpara University of Agriculture, Umudike, Umuahia told a news conference Feb. 1 at Umuahia.
“ Nigeria does not have AMS, as a natural resource, but there is abundance of Aluminum silicate and Magnesium silicate in the country, indeed in commercial quantity, enough to make a difference in the country’s foreign exchange earnings.
“These two minerals, which are also safe medicines were reacted to get a purer form of AMS.’’
He said that these minerals had been in use to potentiate Ampicilin, Chloroquine, Piperazine and Sulphadimidin, among others, and could be a major foreign exchange earner for Nigeria, if approved by relevant authorities.
According to him, local and international pharmaceutical companies will find the product as veritable raw materials.
Ezeibe said that he presented the research findings to the World Virology Conference in Atlanta in 2015, and Antonio (Texas) in 2016.
Besides, he said that the results of the laboratory tests had been published in many international scientific journals, including the British Journal of Medicine and Medical Research, among several others.
He said that he was also about to sign a memorandum of understanding with a U.S.-based Scientific Research Publishing, publishers of World Journal of AIDS, for the publication of his book “How I came about the cure for HIV/AIDS’’.
Ezeibe, who said the medicine was patented in August 2014 in Nigeria, called on the Federal Government to help him to secure international patency for the drug.
According to him, if commercialised, the Medicinal Synthetic Aluminum-Magnesium Silicate will become an alternative for petroleum to the Nigerian economy.
It was at the news conference in Umuahia that Prof. Francis Otunta, the Vice-Chancellor, Michael Okpara University of Agriculture, Umudike, Umuahia, Abia State that confirmed the discovery of a new drug for the treatment and cure of HIV/AIDS by the institution.
Otunta said that the finding followed years of scientific research by the institution and that the breakthrough was made by Prof. Ezeibe, a researcher in the institution.
According to him, Ezeibe had presented the drug to the University management, Senate and Council, where he explained the processes he went through to arrive at his finding.
The VC also said that Ezeibe had presented the drug to his colleagues in the medical field and nobody had contradicted his finding.
“Prof. Ezeibe as a researcher in Veterinary Medicine, one may wonder how he discovered a drug to cure a human ailment,” he said.
He commended Ezeibe for the breakthrough, saying: “he has brought honour to the University and we are proud of him.’’
Otunta said the university was in the process of mass producing the drug for further clinical trials on persons living with HIV/AIDS in the country.
Prof. Ezeibe was a graduate of University of Nigeria, Nsukka from where he obtained Doctor of Veterinary Medicine Degree (DVM), M.Sc and Ph.D.
He is also a fellow of College of Veterinary Surgeons, Nigeria (FCVSN).
Prof Ezeibe has won many academic prizes, including: best student in Veterinary microbiology, pathology, public health and jurisprudence and in Veterinary clinics.
In 2011 he won Federal Government’s Presidential Standing Committee Award, for invention of Medicinal synthetic Aluminum – magnesium silicate (Nanoparticles)- a broad-spectrum antiviral medicine.
These have proved effective against Avian influenza virus, Measles virus, Newcastle disease virus, Peste des petits ruminants virus, Infectious bursal disease virus, Egg drop syndrome 76 virus, Avian pox virus and Canine parvovirus.
No comments:
Post a Comment